Nintedanib in children and adolescents with fibrosing interstitial lung disease: the InPedILD trial

被引：0
|
作者：
Matthias, Griese [1 ]
Robin, Deterding [2 ,3 ]
Lisa, Young R. [4 ]
Emily, DeBoer M. [2 ,3 ]
David, Warburton [5 ,6 ]
Steven, Cunningham [7 ]
Nicolaus, Schwerk [8 ]
Kevin, Flaherty R. [9 ]
Kevin, Brown K. [10 ]
Mihaela, Dumistracel [11 ]
Elvira, Erhardt [12 ]
Julia, Bertulis [12 ]
Martina, Gahlemann [13 ]
Susanne, Stowasser [14 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, German Ctr Lung Res DZL, Munich, Germany
[2] Univ Colorado Denver, Sect Pediat Pulm & Sleep Med, Dept Pediat, Denver, CO USA
[3] Childrens Hosp Colorado, Aurora, CO USA
[4] Childrens Hosp Philadelphia, Div Pulm & Sleep Med, Philadelphia, PA USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA USA
[6] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[7] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
[8] Hannover Med Sch, Clin Pediat Pulmonol Allergol & Neonatol, Hannover, Germany
[9] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[10] Natl Jewish Hlth, Dept Med, Denver, CO USA
[11] Boehringer Ingelheim Pharma GmbH Co KG, Ingelheim, Germany
[12] Boehringer Ingelheim Pharma GmbH Co KG, Biberach, Germany
[13] Boehringer Ingelheim Schweiz GmbH, Basel, Switzerland
[14] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
KLINISCHE PADIATRIE | 2023年 / 235卷 / 02期
关键词：
D O I：
10.1055/s-0043-1761556
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P46
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [41] Nintedanib in children and adolescents with fibrosing ILDs: interim analysis of InPedILDON
    Deterding, Robin
    Young, Lisa
    Deboer, Emily
    Warburton, David
    Cunningham, Steven
    Schwerk, Nicolaus
    Brown, Kevin
    Koucky, Vaclav
    Weinman, Jason P.
    Simmons, Jill
    Dumistracel, Mihaela
    Jantzen, Frauke
    Gahlemann, Martina
    Griese, Matthias
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [42] Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
    Lotte Westerink
    Jelmer Lennart Jens Nicolai
    Maarten Jacobus Postma
    Job Frank Martien van Boven
    Cornelis Boersma
    PharmacoEconomics - Open, 2022, 6 : 647 - 656
  • [43] Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
    Westerink, Lotte
    Nicolai, Jelmer Lennart Jens
    Postma, Maarten Jacobus
    van Boven, Job Frank Martien
    Boersma, Cornelis
    PHARMACOECONOMICS-OPEN, 2022, 6 (05) : 647 - 656
  • [44] Progression of fibrosing interstitial lung disease
    Alyson W. Wong
    Christopher J. Ryerson
    Sabina A. Guler
    Respiratory Research, 21
  • [45] Progression of fibrosing interstitial lung disease
    Wong, Alyson W.
    Ryerson, Christopher J.
    Guler, Sabina A.
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [46] Fibrosing Interstitial Lung Disease in Children: An HRCT-Based Analysis
    Bhalla, Deeksha
    Jana, Manisha
    Naranje, Priyanka
    Bhalla, Ashu Seith
    Kabra, Sushil K.
    INDIAN JOURNAL OF PEDIATRICS, 2023, 90 (02): : 153 - 159
  • [47] Fibrosing Interstitial Lung Disease in Children: An HRCT-Based Analysis
    Deeksha Bhalla
    Manisha Jana
    Priyanka Naranje
    Ashu Seith Bhalla
    Sushil K. Kabra
    Indian Journal of Pediatrics, 2023, 90 : 153 - 159
  • [48] Effects of Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-related Interstitial Lung Diseases (ILDs) in the INBUILD Trial: Subgroups by HRCT Pattern
    Dellaripa, Paul
    Aringer, Martin
    Mann-Vold, Anna Maria Hoff
    Kelly, Clive
    Mittoo, Shikha
    James, Alexandra
    Rohr, Klaus
    Stowasser, Susanne
    Inoue, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [49] INNOVATIVE CLINICAL TRIAL OF NINTEDANIB IN MYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Aggarwal, Rohit
    Oddis, Chester
    Sullivan, Daniel I.
    Moghadam-Kia, Siamak
    Saygin, Didem
    Kass, Daniel
    Koontz, Diane
    Li, Peide
    Conoscenti, Craig S.
    Olson, Amy L.
    CHEST, 2023, 164 (04) : 3060A - 3062A
  • [50] Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
    Madgula, Anantha Sriharsha
    Covello, Brian R.
    Singh, Meghana
    Rao, Arundati
    Lee, Jim C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
12345